About Index Trending news
Analyze
Pricing
Cerulean Pharma, Inc

Cerulean Pharma, Inc

Work at Cerulean Pharma, Inc? Add yourself to this profile

Cerulean Pharma, Inc

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

Elsewhere

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$35,000,000
Debt financing
$26,000,000
Employees

Team size

10+
Locations
HQ
Xconomy

Cerulean's Shares Routed as Cancer Drug Comes up Short Again

Health